Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 28, 2016; 22(40): 8862-8868
Published online Oct 28, 2016. doi: 10.3748/wjg.v22.i40.8862
Published online Oct 28, 2016. doi: 10.3748/wjg.v22.i40.8862
Disease | Therapeutic Genes | Ref. |
Nonalcoholic steatohepatitis | Inducible nitric oxcide synthetase | [8] |
Hepatitis | HBV knockdown | [5,9] |
HCV knockdown | ||
Fulminant hepatitis | NKG2D knockdown | [7,10] |
osteopontin knockdown | ||
Liver injury | c-met | [7,11] |
IL-37 | ||
caspase knockdown | ||
Liver fibrosis | platelet-derived growth factor receptor beta knockdown | [12] |
Liver Regeneration | fibroblast growth factor 7 | [13] |
Fabry disease | alpha-galactosidase A | [7] |
Pancreatitis | pancreatitis associated protein 1 | [14] |
Colon cancer | IL-15 | [15] |
- Citation: Yokoo T, Kamimura K, Abe H, Kobayashi Y, Kanefuji T, Ogawa K, Goto R, Oda M, Suda T, Terai S. Liver-targeted hydrodynamic gene therapy: Recent advances in the technique. World J Gastroenterol 2016; 22(40): 8862-8868
- URL: https://www.wjgnet.com/1007-9327/full/v22/i40/8862.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i40.8862